April 2013 - Cohen & Malad, LLP

FDA Has Growing Concern Over Popular Diabetes Drugs

by: Jeff S. Gibson, Attorney Advances in modern medicine over the past decade have given patients many great treatment options. Drugs have been designed to treat myriad of conditions from heart arrhythmia to kidney disease. Ideally, drug manufacturers have a goal to create medicine for patients that will give them maximum benefit with minimum risk…. Continue Reading »

The Billable Hour Debate

by: Richard E. Shevitz, Attorney The recent revelations that DLA Piper, one of the world’s largest and most prestigious law firms, has apparently intentionally padded its bills to a client who had the audacity to challenge them are, sadly, not shocking to anyone in the legal world. Not that it was specifically, DLA Piper, of… Continue Reading »